Wilbanks Smith & Thomas Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$58.38 - $84.96 $157,334 - $228,967	-2,695 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$62.15 - $90.32 $167,494 - $243,412	2,695 New	2,695 $223,000
Q1 2021 May 11, 2021	SELL	$61.35 - $90.47 $165,338 - $243,816	-2,695 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $118,094 - $230,072	2,695 New	2,695 $207,000
Q4 2018 Feb 08, 2019	SELL	$10.74 - $19.7 $39,738 - $72,890	-3,700 Closed	0 $0

Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $51,800 - $75,110	3,700 New	3,700 $71,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account